Presenters
Paul Slater
Co-founder, Life Sciences Innovation, Microsoft, United States
Paul Slater is the Worldwide Industry Strategist for Pharmaceuticals in the Microsoft Health Industry team. In this role, he is responsible for defining Microsoft’s life sciences strategy, developing strategic relationships and partnerships with key life sciences customers and partners, building industry-leading solutions that showcase Microsoft technologies, and educating the Microsoft internal community on the needs of the industry. Under Paul’s leadership, Microsoft is working with partners to develop innovative platforms and solutions that span the life sciences value chain from discovery and development, through manufacturing and distribution to commercialization.
Matt Neal, MA
Senior Director, Regulatory Affairs Operations, Atara Biotherapuetics, United States
Matt Neal is an author and frequent keynote speaker. He joined Atara Biotherapeutics in 2019 as the Head of Regulatory Operations. Prior to that, Matt was the Head of Product Management for the InSight Suite of Regulatory Information Management Solutions at Parexel, Inc. and partnered with Microsoft. Before joining PAREXEL, Matt was a Director of Regulatory & Safety Operations at Amgen, Inc. (2003-2016) and was one of the pioneering members of the Regulatory Submissions Department for GlaxoSmithKline (1996-2003). Matt has been publishing and submitting electronic dossiers to the FDA since 1996, and submitted the very first fully electronic NDA for GSK in 1999.
Meredith K Sewell
Vice President, Regulatory Operations, Sarepta Therapeutics, United States
Meredith Sewell is Sarepta’s Executive Director of Global Regulatory Operations, heading up the RIM and Submissions space. Meredith joined the company in 2019, and is enjoying working at a smaller, rare disease, gene therapy company after 14 years in Reg Ops at Allergan, and prior to that, Amgen Inc.
Have an account?